Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 5
2000 4
2001 4
2002 3
2003 2
2004 1
2005 2
2006 3
2007 1
2008 3
2009 7
2010 4
2011 5
2012 1
2013 5
2014 2
2015 1
2016 3
2018 1
2019 1
2020 7
2022 5
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
How latanoprost changed glaucoma management.
Cordeiro MF, Gandolfi S, Gugleta K, Normando EM, Oddone F. Cordeiro MF, et al. Among authors: gugleta k. Acta Ophthalmol. 2024 Mar;102(2):e140-e155. doi: 10.1111/aos.15725. Epub 2023 Jun 23. Acta Ophthalmol. 2024. PMID: 37350260 Review.
Ocular perfusion pressure in glaucoma.
Costa VP, Harris A, Anderson D, Stodtmeister R, Cremasco F, Kergoat H, Lovasik J, Stalmans I, Zeitz O, Lanzl I, Gugleta K, Schmetterer L. Costa VP, et al. Among authors: gugleta k. Acta Ophthalmol. 2014 Jun;92(4):e252-66. doi: 10.1111/aos.12298. Epub 2013 Nov 18. Acta Ophthalmol. 2014. PMID: 24238296 Free article. Review.
The Role of Rho Kinase Inhibitors in Corneal Diseases.
Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z. Futterknecht S, et al. Among authors: gugleta k. Drug Des Devel Ther. 2024 Jan 19;18:97-108. doi: 10.2147/DDDT.S435522. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38264539 Free PMC article. Review.
Therapeutic strategies for normal-tension glaucoma.
Orgul S, Zawinka C, Gugleta K, Flammer J. Orgul S, et al. Among authors: gugleta k. Ophthalmologica. 2005 Nov-Dec;219(6):317-23. doi: 10.1159/000088372. Ophthalmologica. 2005. PMID: 16286789 Review.
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
Cerdá-Fuertes N, Stoessel M, Mickeliunas G, Pless S, Cagol A, Barakovic M, Maceski AM, Álvarez González C, D' Souza M, Schaedlin S, Benkert P, Calabrese P, Gugleta K, Derfuss T, Sprenger T, Granziera C, Naegelin Y, Kappos L, Kuhle J, Papadopoulou A. Cerdá-Fuertes N, et al. Among authors: gugleta k. Mult Scler. 2023 Nov;29(13):1540-1550. doi: 10.1177/13524585231198760. Epub 2023 Sep 29. Mult Scler. 2023. PMID: 37772490 Free PMC article.
Is neurovascular coupling of relevance in glaucoma?
Gugleta K, Fuchsjäger-Mayrl G, Orgül S. Gugleta K, et al. Surv Ophthalmol. 2007 Nov;52 Suppl 2:S139-43. doi: 10.1016/j.survophthal.2007.08.009. Surv Ophthalmol. 2007. PMID: 17998039 Review.
Use of colour Doppler imaging in ocular blood flow research.
Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G, Grunwald J, Gugleta K, Harris A, Hudson C, Januleviciene I, Kagemann L, Kergoat H, Lovasik JV, Lanzl I, Martinez A, Nguyen QD, Plange N, Reitsamer HA, Sehi M, Siesky B, Zeitz O, Orgül S, Schmetterer L. Stalmans I, et al. Among authors: gugleta k. Acta Ophthalmol. 2011 Dec;89(8):e609-30. doi: 10.1111/j.1755-3768.2011.02178.x. Epub 2011 Oct 11. Acta Ophthalmol. 2011. PMID: 21989301 Free article. Review.
79 results